Diabetes medications and cardiovascular outcome trials: Lessons learned

被引：11
|
作者：
Patel, Kershaw V. [1 ]
Rocha, Natalia de Albuquerque [1 ]
McGuire, Darren K. [1 ]
机构：
[1] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Div Cardiol, Dallas, TX USA
来源：
CLEVELAND CLINIC JOURNAL OF MEDICINE | 2017年 / 84卷 / 10期
关键词：
HEART-FAILURE; MYOCARDIAL-INFARCTION; DOUBLE-BLIND; TYPE-2; SITAGLIPTIN; MELLITUS; INHIBITION; EXENATIDE; IMPROVES; COTRANSPORTERS;
D O I：
10.3949/ccjm.84gr.17006
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The US Food and Drug Administration's current standards require that new diabetes medications demonstrate cardiovascular safety in large, long-term trials. New drugs that have been assessed in such trials are changing the management of type 2 diabetes.
引用
收藏
页码：759 / 767
页数：9
相关论文
共 50 条
  • [1] Cardiovascular outcome trials of diabetes drugs: lessons learned
    Taylor, Simeon I.
    Leslie, Bruce R.
    JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (03): : 893 - 896
  • [2] Adherence to Cardiovascular Medications: Lessons Learned and Future Directions
    Kronish, Ian M.
    Ye, Siqin
    PROGRESS IN CARDIOVASCULAR DISEASES, 2013, 55 (06) : 590 - 600
  • [3] Pediatric Cardiovascular Drug Trials, Lessons Learned
    Li, Jennifer S.
    Cohen-Wolkowiez, Michael
    Pasquali, Sara K.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2011, 58 (01) : 4 - 8
  • [4] Updates on cardiovascular outcome trials in diabetes
    Schnell, Oliver
    Ryden, Lars
    Standl, Eberhard
    Ceriello, Antonio
    CARDIOVASCULAR DIABETOLOGY, 2017, 16
  • [5] Updates on cardiovascular outcome trials in diabetes
    Oliver Schnell
    Lars Rydén
    Eberhard Standl
    Antonio Ceriello
    Cardiovascular Diabetology, 16
  • [6] Endpoints in diabetes cardiovascular outcome trials
    Patel, Tejas
    Tesfaldet, Bereket
    Chowdhury, Iffat
    Kettermann, Anna
    Smith, James P.
    Pucino, Frank
    Almario, Eileen E. Navarro
    LANCET, 2018, 391 (10138): : 2412 - 2412
  • [7] Important Considerations for the Treatment of Patients with Diabetes Mellitus and Heart Failure from a Diabetologist's Perspective: Lessons Learned from Cardiovascular Outcome Trials
    Koliaki, Chrysi
    Katsilambros, Nicholas
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2020, 17 (01)
  • [8] Cardiovascular outcome trials of glucose-lowering medications: an update
    Home, Philip
    DIABETOLOGIA, 2019, 62 (03) : 357 - 369
  • [9] Cardiovascular outcome trials of the newer anti-diabetic medications
    Acharya, Tushar
    Deedwania, Prakash
    PROGRESS IN CARDIOVASCULAR DISEASES, 2019, 62 (04) : 342 - 348
  • [10] Cardiovascular outcome trials of glucose-lowering medications: an update
    Philip Home
    Diabetologia, 2019, 62 : 357 - 369
12345